Auph pipeline
WebAug 18, 2024 · Aurinia AUPH announced that it has acquired two new pipeline candidates, which will target rare autoimmune and kidney-related diseases. Both the candidates, renamed as AUR200 and AUR300 following ... WebOur Medicine. Product. Patient Safety. Full Prescribing Information, Including Boxed Warning. Medication Guide. Consumer Website. HCP Website. Aurinia Alliance TM Patient Support Program.
Auph pipeline
Did you know?
WebAug 18, 2024 · Aurinia AUPH announced that it has acquired two new pipeline candidates, which will target rare autoimmune and kidney-related diseases. Both the candidates, … WebFeb 16, 2024 · Pipeline. Overview; Clinical programs; Clinical trials; Pre-approval access policy; Investigator sponsored research; Independent medical education; Medicines; …
WebAUGMENT-102. MLLr ALL/MPAL/AML, mNPM1 AML. Phase 1. Axatilimab (SNDX-6352) WebFeb 23, 2024 · Madrigal is a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases. Our most advanced clinical candidate, resmetirom, …
WebDec 10, 2024 · AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today. ... 20 potential high value pipeline assets, and technology platforms. GlobeNewsWire • 12/02/21. 7 Drug Stocks to Buy Now While They're Still on Sale. InvestorPlace • 11/30/21. Novartis chairman says all options open for Sandoz unit - report. Web2 days ago · Aurinia Pharmaceuticals (AUPH) announces the issue of its new and refined method-of-use patent, supplementing its existing patent, for Lupkynis to treat lupus nephritis. Shares are up 11%. 2d ago
WebAug 17, 2024 · VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of building out and …
WebDec 3, 2024 · Shares of Aurinia Pharmaceuticals Inc. AUPH gained 13.2% on Dec 2, following fresh rumors of a potential buyout. Reportedly, Swiss pharma giant Novartis NVS is looking out for small bolt-on ... hawai routardWebAug 17, 2024 · Aurinia Pharmaceuticals Inc. ( AUPH) stock fell today after the company announced the addition of two novel assets that will expand the company’s rare autoimmune and kidney-related disease pipeline. The new compounds include B-cell therapy (BAFF/APRIL) and macrophage modulation. Shares of AUPH declined 9.97% to $13.02 … hawair systemairWebAug 17, 2024 · Aurinia Pharmaceuticals Inc AUPH has added two assets to expand its rare autoimmune and kidney-related disease pipeline. The first program, AUR200, was … hawai remix translationWebApr 11, 2024 · EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the United States Patent and Trademark Office (USPTO) has issued a new and refined method of use patent titled IMPROVED PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS. haw airlines.comWeb02/28 06:43. -- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q4 Revenue $28.4M, vs. Street Est of $28.8M. MT Newswires. 02/28 06:01. Aurinia Reports Fourth … boson god particleWebAug 17, 2024 · Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has added two assets to expand its rare autoimmune and kidney-related disease pipeline.; The first program, AUR200, was acquired from privately-held ... bosonhiggs1 outlook.comWebAUR300 is a novel peptide therapeutic that modulates M2 macrophages (a type of white blood cells) via the macrophage mannose receptor CD206. Dysregulation of M2 … Our Pipeline; Our Medicine. Product; Patient Safety; For Patients/Healthcare Pro… Changing the course of autoimmune disease. Aurinia exists to make a difference… Aurinia Pharmaceuticals Inc. Address. Canada Aurinia Corporate Headquarters #… Resources Helping people living with autoimmune disease inspires our work. Aur… bosoni andrea